Compare Stocks

→ Will this $2 AI stock double overnight? (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYP Cypress Development	C$1.09 +1.4%	C$1.09	C$0.84 ▼ C$2.14	C$159.72M	N/A	71,527 shs	33,605 shs
ONC Oncolytics Biotech	C$1.47 +2.8%	C$1.44	C$1.20 ▼ C$4.49	C$110.87M	1.49	77,454 shs	29,418 shs
PDP Invesco Dorsey Wright Momentum ETF	$93.74 0.0%	$95.45	$72.68 ▼ $99.60	$1.21B	1.02	26,501 shs	30,299 shs
SBM ProShares Short Basic Materials	$46.38	$46.38	$42.85 ▼ $55.15	$1.86M	N/A	3,024 shs	N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYP Cypress Development	0.00%	0.00%	0.00%	0.00%	0.00%
ONC Oncolytics Biotech	+2.80%	+2.08%	+5.00%	-13.53%	-5.16%
PDP Invesco Dorsey Wright Momentum ETF	-0.03%	+1.03%	-4.59%	+7.55%	+26.10%
SBM ProShares Short Basic Materials	0.00%	0.00%	0.00%	0.00%	-0.01%

Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)

The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...

CLICK HERE TO GET YOUR GUIDE NOW

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CYP Cypress Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	0.5916 of 5 stars	3.5	0.0	0.0	0.0	1.1	0.0	0.0
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CYP Cypress Development	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	3.00	Buy	C$6.00	308.16% Upside
PDP Invesco Dorsey Wright Momentum ETF	0.00	N/A	$96.48	2.92% Upside
SBM ProShares Short Basic Materials	0.00	N/A	N/A	N/A

Current Analyst Ratings

Latest ONC, SBM, PDP, and CYP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/4/2024	ONC Oncolytics Biotech	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform	C$3.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CYP Cypress Development	N/A	N/A	C$0.24 per share	4.49	C$0.39 per share	N/A
ONC Oncolytics Biotech	N/A	N/A	C$0.35 per share	4.22	C$0.37 per share	N/A
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CYP Cypress Development	N/A	-C$0.03	N/A	∞	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	-C$27.75M	-C$0.41	N/A	∞	N/A	N/A	-102.66%	-55.47%	5/3/2024 (Estimated)
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	25.46	∞	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest ONC, SBM, PDP, and CYP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/7/2024	Q4 2023	ONC Oncolytics Biotech	-C$0.15	-C$0.05	+C$0.10	-C$0.05	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CYP Cypress Development	N/A	N/A	N/A	N/A	N/A
ONC Oncolytics Biotech	N/A	N/A	N/A	N/A	N/A
PDP Invesco Dorsey Wright Momentum ETF	$0.25	0.27%	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A

Latest ONC, SBM, PDP, and CYP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/15/2024	PDP Invesco Dorsey Wright Momentum ETF	Quarterly	$0.0275		3/18/2024	3/19/2024	3/22/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CYP Cypress Development	1.50	42.83	42.15
ONC Oncolytics Biotech	1.54	9.01	8.86
PDP Invesco Dorsey Wright Momentum ETF	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
CYP Cypress Development	N/A
ONC Oncolytics Biotech	6.98%
PDP Invesco Dorsey Wright Momentum ETF	N/A
SBM ProShares Short Basic Materials	N/A

Insider Ownership

Company	Insider Ownership
CYP Cypress Development	N/A
ONC Oncolytics Biotech	6.24%
PDP Invesco Dorsey Wright Momentum ETF	N/A
SBM ProShares Short Basic Materials	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CYP Cypress Development	N/A	146.53 million	N/A	Not Optionable
ONC Oncolytics Biotech	29	75.42 million	N/A	Not Optionable
PDP Invesco Dorsey Wright Momentum ETF	N/A	12.89 million	N/A	Optionable
SBM ProShares Short Basic Materials	N/A	40,000	N/A	Not Optionable

ONC, SBM, PDP, and CYP Headlines

Source	Headline
	FTSEAthex Basic Materials (FTATBM) investing.com - April 17 at 1:11 PM
	Fundamentals of Materials for Energy and Environmental Sustainability cambridge.org - March 24 at 5:46 PM
	Sh4b set aside for CBC classrooms missing standardmedia.co.ke - February 25 at 10:22 PM
	TTT ProShares UltraPro Short 20+ Year Treasury ETF seekingalpha.com - December 24 at 6:36 PM
	ProShares Short Basic Materials (SBM) finance.yahoo.com - November 23 at 7:46 AM
	All Indices thestreet.com - September 18 at 9:22 PM
	ProShares Short Financials (SEF) investing.com - August 24 at 3:19 PM
	ProShares Short Basic Materials News thestreet.com - August 23 at 11:58 PM
	Volatile Market Conditions Could Drive Investors to Trade investopedia.com - July 23 at 10:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
April 2, 2024 9:15 AM
View Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
April 2, 2024 11:25 AM
View Tesla Stock Drops on Weak Delivery Numbers and it May Fall More
Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
April 5, 2024 8:45 AM
View Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
March 26, 2024 7:00 AM
View Tesla Is the Analyst's Most Downgraded Stock: How Low Can It Go?
Cannabis: One Stock to Play the Movement
April 8, 2024 8:38 AM
View Cannabis: One Stock to Play the Movement

All Headlines

Company Descriptions

Cypress Development

CVE:CYP

Cypress Development Corp. engages in the acquisition, exploration, evaluation, and development of mineral properties in the United States and Canada. It explores for lithium, zinc, and silver deposits. The company's flagship project is the Clayton Valley project that covers an area of approximately 5,430 acres located in southwest Nevada. Cypress Development Corp. was incorporated in 1991 and is headquartered in Vancouver, Canada.

Oncolytics Biotech

TSE:ONC

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Invesco Dorsey Wright Momentum ETF

NASDAQ:PDP

PowerShares DWA Technical Leaders Portfolio (the Fund) is based on the Dorsey Wright Technical Leaders Index (the Index). The Fund seeks investment results that generally correspond to the price and yield of the Index. The Fund will normally invest at least 90% of its total assets in securities that consists of the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index includes approximately 100 the United States-listed companies. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.

ProShares Short Basic Materials

NYSEARCA:SBM

ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial